e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Translational studies in chronic lung diseases: from bedside to bench
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Involvement of asparatic acid racemization and isomerization in the pathogenesis of COPD
R. Koizumi, M. Ogasawara, N. Sasaki, T. Tanita, Y. Nakamura, K. Yamauchi (Morioka, Toon, Japan)
Source:
Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Session:
Translational studies in chronic lung diseases: from bedside to bench
Session type:
Poster Discussion
Number:
246
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Koizumi, M. Ogasawara, N. Sasaki, T. Tanita, Y. Nakamura, K. Yamauchi (Morioka, Toon, Japan). Involvement of asparatic acid racemization and isomerization in the pathogenesis of COPD. Eur Respir J 2013; 42: Suppl. 57, 246
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD?
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Effect of antioxidants, L-2-oxothiazolidine-4-carboxylic acid and α-lipoic acid, on airway remodeling in chronic model of allergic airway disease
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Reduction of high mobility group nucleosome binding domain-5 protein promotes the development of emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Different response of lung tissue to intravenous acetylated opium
Source: International Congress 2015 – Different data in COPD
Year: 2015
Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
The lipokine, or palmitoleic acid (16:1), is a biomarker of lung function in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
LSC 2014 abstract - The role of the formyl peptide receptor in the development of pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Prooxidant-antioxidant balance in mustard airway disease with different severity
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Local and systemic nucleic acid damage in COPD exacerbations.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Fatty acid blood spectrum in patients with asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept